Proactiveinvestors Australia - Pharmaceuticals RSS feed http://www.proactiveinvestors.com.au Proactiveinvestors Australia - Pharmaceuticals feed en Sun, 21 Jan 2018 17:09:15 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com action@proactiveinvestors.com AusCann Group to collaborate in enhancing medicinal cannabis production http://www.proactiveinvestors.com.au/companies/news/190143/auscann-group-to-collaborate-in-enhancing-medicinal-cannabis-production-190143.html Wed, 17 Jan 2018 14:47:00 +1100 http://www.proactiveinvestors.com.au/companies/news/190143/auscann-group-to-collaborate-in-enhancing-medicinal-cannabis-production-190143.html Auscann Group’s shares surge following green light for medicinal cannabis export http://www.proactiveinvestors.com.au/companies/news/189492/auscann-groups-shares-surge-following-green-light-for-medicinal-cannabis-export-189492.html Thu, 04 Jan 2018 14:35:00 +1100 http://www.proactiveinvestors.com.au/companies/news/189492/auscann-groups-shares-surge-following-green-light-for-medicinal-cannabis-export-189492.html AusCann Group Holdings advances medical cannabis supply chain strategy http://www.proactiveinvestors.com.au/companies/news/188920/auscann-group-holdings-advances-medical-cannabis-supply-chain-strategy-188920.html Mon, 18 Dec 2017 14:51:00 +1100 http://www.proactiveinvestors.com.au/companies/news/188920/auscann-group-holdings-advances-medical-cannabis-supply-chain-strategy-188920.html AusCann Group Holdings shares pop on grant of new medical cannabis licence http://www.proactiveinvestors.com.au/companies/news/188402/auscann-group-holdings-shares-pop-on-grant-of-new-medical-cannabis-licence-188402.html Thu, 07 Dec 2017 10:59:00 +1100 http://www.proactiveinvestors.com.au/companies/news/188402/auscann-group-holdings-shares-pop-on-grant-of-new-medical-cannabis-licence-188402.html AusCann Group Holdings to reveal next medical cannabis steps in Australia http://www.proactiveinvestors.com.au/companies/news/188314/auscann-group-holdings-to-reveal-next-medical-cannabis-steps-in-australia-188314.html Wed, 06 Dec 2017 10:04:00 +1100 http://www.proactiveinvestors.com.au/companies/news/188314/auscann-group-holdings-to-reveal-next-medical-cannabis-steps-in-australia-188314.html AusCann Group Holdings secures medical cannabis cultivation licence http://www.proactiveinvestors.com.au/companies/news/187612/auscann-group-holdings-secures-medical-cannabis-cultivation-licence-187612.html Wed, 22 Nov 2017 10:44:00 +1100 http://www.proactiveinvestors.com.au/companies/news/187612/auscann-group-holdings-secures-medical-cannabis-cultivation-licence-187612.html AusCann Group Holdings to reveal medical cannabis joint venture update http://www.proactiveinvestors.com.au/companies/news/187539/auscann-group-holdings-to-reveal-medical-cannabis-joint-venture-update-187539.html Tue, 21 Nov 2017 10:00:00 +1100 http://www.proactiveinvestors.com.au/companies/news/187539/auscann-group-holdings-to-reveal-medical-cannabis-joint-venture-update-187539.html AusCann Group Holdings welcomes medical cannabis legislation http://www.proactiveinvestors.com.au/companies/news/185925/auscann-group-holdings-welcomes-medical-cannabis-legislation-185925.html Fri, 20 Oct 2017 16:27:00 +1100 http://www.proactiveinvestors.com.au/companies/news/185925/auscann-group-holdings-welcomes-medical-cannabis-legislation-185925.html Botanix Pharmaceuticals to commence acne treatment patient study http://www.proactiveinvestors.com.au/companies/news/182757/botanix-pharmaceuticals-to-commence-acne-treatment-patient-study-182757.html Tue, 22 Aug 2017 08:50:00 +1000 http://www.proactiveinvestors.com.au/companies/news/182757/botanix-pharmaceuticals-to-commence-acne-treatment-patient-study-182757.html Botanix Pharmaceuticals' shares halted pending ethics approval update http://www.proactiveinvestors.com.au/companies/news/182565/botanix-pharmaceuticals-shares-halted-pending-ethics-approval-update-182565.html Thu, 17 Aug 2017 10:34:00 +1000 http://www.proactiveinvestors.com.au/companies/news/182565/botanix-pharmaceuticals-shares-halted-pending-ethics-approval-update-182565.html AusCann Group Holdings Ltd granted Australian medicinal cannabis manufacturing licence http://www.proactiveinvestors.com.au/companies/news/182157/auscann-group-holdings-ltd-granted-australian-medicinal-cannabis-manufacturing-licence-182157.html Wed, 09 Aug 2017 13:22:00 +1000 http://www.proactiveinvestors.com.au/companies/news/182157/auscann-group-holdings-ltd-granted-australian-medicinal-cannabis-manufacturing-licence-182157.html ImpediMed enrols first patient in chronic heart failure trial http://www.proactiveinvestors.com.au/companies/news/182099/impedimed-enrols-first-patient-in-chronic-heart-failure-trial-182099.html Tue, 08 Aug 2017 15:44:00 +1000 http://www.proactiveinvestors.com.au/companies/news/182099/impedimed-enrols-first-patient-in-chronic-heart-failure-trial-182099.html AusCann Group to outline next medicinal cannabis steps in Australia http://www.proactiveinvestors.com.au/companies/news/182085/auscann-group-to-outline-next-medicinal-cannabis-steps-in-australia-182085.html Tue, 08 Aug 2017 13:02:00 +1000 http://www.proactiveinvestors.com.au/companies/news/182085/auscann-group-to-outline-next-medicinal-cannabis-steps-in-australia-182085.html Cogstate Ltd to update on submission to U.S. FDA http://www.proactiveinvestors.com.au/companies/news/181439/cogstate-ltd-to-update-on-submission-to-us-fda-181439.html Wed, 26 Jul 2017 09:41:00 +1000 http://www.proactiveinvestors.com.au/companies/news/181439/cogstate-ltd-to-update-on-submission-to-us-fda-181439.html AusCann Group Holdings Ltd secures two licences http://www.proactiveinvestors.com.au/companies/news/180640/auscann-group-holdings-ltd-secures-two-licences-180640.html Tue, 11 Jul 2017 10:00:00 +1000 http://www.proactiveinvestors.com.au/companies/news/180640/auscann-group-holdings-ltd-secures-two-licences-180640.html Botanix Pharmaceuticals Ltd crosses a milestone in product development http://www.proactiveinvestors.com.au/companies/news/180180/botanix-pharmaceuticals-ltd-crosses-a-milestone-in-product-development-180180.html Mon, 03 Jul 2017 12:00:00 +1000 http://www.proactiveinvestors.com.au/companies/news/180180/botanix-pharmaceuticals-ltd-crosses-a-milestone-in-product-development-180180.html Botanix Pharmaceuticals to reveal clinical results http://www.proactiveinvestors.com.au/companies/news/180093/botanix-pharmaceuticals-to-reveal-clinical-results-180093.html Fri, 30 Jun 2017 12:00:00 +1000 http://www.proactiveinvestors.com.au/companies/news/180093/botanix-pharmaceuticals-to-reveal-clinical-results-180093.html AusCann Group Holdings makes new appointments http://www.proactiveinvestors.com.au/companies/news/179279/auscann-group-holdings-makes-new-appointments-179279.html Thu, 15 Jun 2017 15:00:00 +1000 http://www.proactiveinvestors.com.au/companies/news/179279/auscann-group-holdings-makes-new-appointments-179279.html ImpediMed begins lymphoedema study using its health device http://www.proactiveinvestors.com.au/companies/news/179229/impedimed-begins-lymphoedema-study-using-its-health-device-179229.html Thu, 15 Jun 2017 09:00:00 +1000 http://www.proactiveinvestors.com.au/companies/news/179229/impedimed-begins-lymphoedema-study-using-its-health-device-179229.html AusCann Group Holdings welcomes regulatory change http://www.proactiveinvestors.com.au/companies/news/179186/auscann-group-holdings-welcomes-regulatory-change-179186.html Wed, 14 Jun 2017 10:00:00 +1000 http://www.proactiveinvestors.com.au/companies/news/179186/auscann-group-holdings-welcomes-regulatory-change-179186.html Botanix Pharmaceuticals raises $7.4M to advance product development http://www.proactiveinvestors.com.au/companies/news/178091/botanix-pharmaceuticals-raises-74m-to-advance-product-development-178091.html Mon, 22 May 2017 11:00:00 +1000 http://www.proactiveinvestors.com.au/companies/news/178091/botanix-pharmaceuticals-raises-74m-to-advance-product-development-178091.html AusCann Group Holdings secures medical cannabis funding http://www.proactiveinvestors.com.au/companies/news/178032/auscann-group-holdings-secures-medical-cannabis-funding-178032.html Fri, 19 May 2017 13:00:00 +1000 http://www.proactiveinvestors.com.au/companies/news/178032/auscann-group-holdings-secures-medical-cannabis-funding-178032.html AusCann Group Holdings in halt ahead of capital raising http://www.proactiveinvestors.com.au/companies/news/177885/auscann-group-holdings-in-halt-ahead-of-capital-raising-177885.html Wed, 17 May 2017 11:00:00 +1000 http://www.proactiveinvestors.com.au/companies/news/177885/auscann-group-holdings-in-halt-ahead-of-capital-raising-177885.html AusCann Group Holdings partners with Tasmanian Alkaloids http://www.proactiveinvestors.com.au/companies/news/177879/auscann-group-holdings-partners-with-tasmanian-alkaloids-177879.html Wed, 17 May 2017 09:00:00 +1000 http://www.proactiveinvestors.com.au/companies/news/177879/auscann-group-holdings-partners-with-tasmanian-alkaloids-177879.html Botanix Pharmaceuticals begins first clinical study of acne product http://www.proactiveinvestors.com.au/companies/news/177404/botanix-pharmaceuticals-begins-first-clinical-study-of-acne-product-177404.html Mon, 08 May 2017 10:30:00 +1000 http://www.proactiveinvestors.com.au/companies/news/177404/botanix-pharmaceuticals-begins-first-clinical-study-of-acne-product-177404.html AusCann Group Holdings wins medical cannabis licence http://www.proactiveinvestors.com.au/companies/news/177343/auscann-group-holdings-wins-medical-cannabis-licence-177343.html Fri, 05 May 2017 12:00:00 +1000 http://www.proactiveinvestors.com.au/companies/news/177343/auscann-group-holdings-wins-medical-cannabis-licence-177343.html AusCann Group Holdings in an ASX trading halt pending update http://www.proactiveinvestors.com.au/companies/news/177267/auscann-group-holdings-in-an-asx-trading-halt-pending-update-177267.html Thu, 04 May 2017 10:30:00 +1000 http://www.proactiveinvestors.com.au/companies/news/177267/auscann-group-holdings-in-an-asx-trading-halt-pending-update-177267.html AusCann Group Holdings harvesting first crop in Chile http://www.proactiveinvestors.com.au/companies/news/176195/auscann-group-holdings-harvesting-first-crop-in-chile-176195.html Mon, 10 Apr 2017 12:00:00 +1000 http://www.proactiveinvestors.com.au/companies/news/176195/auscann-group-holdings-harvesting-first-crop-in-chile-176195.html Botanix Pharmaceuticals raising $7.4M for synthetic cannabidiol products http://www.proactiveinvestors.com.au/companies/news/175966/botanix-pharmaceuticals-raising-74m-for-synthetic-cannabidiol-products-175966.html Wed, 05 Apr 2017 11:00:00 +1000 http://www.proactiveinvestors.com.au/companies/news/175966/botanix-pharmaceuticals-raising-74m-for-synthetic-cannabidiol-products-175966.html AusCann Group Holdings to benefit from federal government changes http://www.proactiveinvestors.com.au/companies/news/173581/auscann-group-holdings-to-benefit-from-federal-government-changes-173581.html Thu, 23 Feb 2017 11:30:00 +1100 http://www.proactiveinvestors.com.au/companies/news/173581/auscann-group-holdings-to-benefit-from-federal-government-changes-173581.html Auscann Group Holdings positioned to be a leading supplier of Australian cannabinoid http://www.proactiveinvestors.com.au/companies/stocktube/7940 Elaine Darby, managing director for AusCann Group Holdings, speaks with Proactive Investors.

]]>
Thu, 17 Aug 2017 08:30:00 +1000 http://www.proactiveinvestors.com.au/companies/stocktube/7940
Orphan drug status for new compound 'great news' says Amryt Pharma PLC's COO http://www.proactiveinvestors.com.au/companies/stocktube/6339 Amryt Pharma PLC (LON:AMYT) has been granted orphan drug status in the US for  a compound called AP102 to treat patients with the excess growth condition acromegaly. Chief operating officer Rory Nealon tells Proactive: ''Our focus is to acquire, develop and commercialise products in the orphan drug space ... acromegaly is exactly that, it is classified as an orphan condition with an estimated prevalence of 60 patients per million of population''.
''Orphan status is the same in Europe and the USA - it's designed to encourage companies like ourselves to develop treatments for rare conditions. We get marketing exclusivity and also don't require the same number of patients for clinical trials'', Nealon added. Amryt has already been awarded orphan drug status for its lead drug EpiSalven, to treat the skin disorder Epidermolysis Bullosa, which is being prepared for a phase III trial early next year.

]]>
Tue, 08 Nov 2016 01:10:00 +1100 http://www.proactiveinvestors.com.au/companies/stocktube/6339
Faron Pharmaceuticals Oy boss pleased with healthier than expected cash balance http://www.proactiveinvestors.com.au/companies/stocktube/5814 Faron Pharmaceuticals Oy (LON:FARN) ended the first half of 2016 with more cash than it had anticipated.

Research & development (R&D) expenses more than doubled, but the combination of higher than anticipated income, in the form of both revenue and grant income, and lower operating costs meant the company experienced only a modest cash outflow over the reporting period.

Chief executive Dr Markku Jalkanen told Proactive revenue comprised mostly of a €750,000 signing fee from Pharmbio and a €356,500 pre-payment relating to IFB-beta production.

The group also received €968,000 from the European Union from its FP7 Traumakine grant.

The company had a cash balance of €8.9mln at the end of June, it revealed in its results for the first half of the year.

]]>
Wed, 07 Sep 2016 00:25:00 +1000 http://www.proactiveinvestors.com.au/companies/stocktube/5814